SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
SMITH JOEL A III

(Last) (First) (Middle)
2584 JUNCTION AVENUE

(Street)
SAN JOSE CA 95134

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OCLARO, INC. [ OCLR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/27/2009
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/27/2009 A 3,613 A $0(1) 46,364 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $320.17(2) 04/27/2009 A 3,613 04/27/2009 10/24/2010 Common Stock 3,613 $0 3,613 D
Stock Option (Right to Buy) $12.58(2) 04/27/2009 A 3,613 04/27/2009 10/19/2010 Common Stock 3,613 $0 3,613 D
Stock Option (Right to Buy) $13.52(2) 04/27/2009 A 2,713 04/27/2009 10/18/2010 Common Stock 2,713 $0 2,713 D
Stock Option (Right to Buy) $2.05(2) 04/27/2009 A 3,613 04/27/2009 10/24/2012 Common Stock 3,613 $0 3,613 D
Stock Option (Right to Buy) $2.8(2) 04/27/2009 A 1,806 04/27/2009 10/18/2012 Common Stock 1,806 $0 1,806 D
Stock Option (Right to Buy) $13.99(2) 04/27/2009 A 3,613 04/27/2009 11/06/2013 Common Stock 3,613 $0 3,613 D
Stock Option (Right to Buy) $7.61(2) 04/27/2009 A 7,232 04/27/2009 11/01/2014 Common Stock 7,232 $0 7,232 D
Stock Option (Right to Buy) $2.08(2) 04/27/2009 A 7,232 04/27/2009 10/27/2015 Common Stock 7,232 $0 7,232 D
Stock Option (Right to Buy) $4.21(2) 04/27/2009 A 7,232 04/27/2009 11/03/2016 Common Stock 7,232 $0 7,232 D
Stock Option (Right to Buy) $4.35(2) 04/27/2009 A 7,232 04/27/2009 11/15/2017 Common Stock 7,232 $0 7,232 D
Stock Option (Right to Buy) $0.3(2) 04/27/2009 A 7,232 04/27/2009 11/13/2018 Common Stock 7,232 $0 7,232 D
Explanation of Responses:
1. Reporting Person received such shares in exchange for shares of Avanex Corporation ("Avanex") common stock in connection with the merger of Avanex into Oclaro, Inc. (formerly known as Bookham) (the "Merger"). Pursuant to the terms of the Merger agreement each share of Avanex common stock will automatically be converted into the right to receive 5.426 shares of Bookham common stock.
2. Reporting Person received such stock option in exchange for a stock option to purchase Avanex common stock in connection with the Merger. Pursuant to the terms of the Merger agreement each Avanex stock option assumed will be determined by multiplying the number of options by the exchange ratio of 5.426 and rounded down to the nearest whole number.
Remarks:
Christopher Croddy, Attorney-in-Fact 04/29/2009
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.